HHS orders 6 drugmakers to repay providers for violating 340B
Dive Brief: HHS’ Health Resources and Services Administration called out six pharmaceutical companies Tuesday for violating rules under the 340B drug discount program, ordering them to repay affected providers for previous overcharges and warning of more penalties if they don’t comply. In July 2020 some drugmakers stopped giving the 340B ceiling price on their products… Read More »